Who shouldn't get a collagen biostimulator

The list of biostimulator contraindications that circulates online is almost always the same one, copied from the package insert, and it has a problem: it lumps three very different things into a single block.

There is the absolute contraindication — you don't do it, period. There is the relative one — it depends on assessment, and the answer changes from person to person. And there is the postponement — it's not that you can never have it, it's that you can't have it now.

Anyone who reads the list straight through walks away thinking they're ruled out when they aren't, or thinking they're a candidate when their face actually called for a different conversation. I'll separate the three.

The absolute contraindications

There are few of them, and they are firm:

• Known allergy to the product or to any component of the formulation. This applies to poly-L-lactic acid, to calcium hydroxylapatite and to the carrier gels. A documented allergy takes the product off the table — you don't lower the dose, dilute it further or test "just a tiny bit".
• Active infection in the treatment area. An active cold sore, folliculitis, inflamed acne with pustules, any infectious process in the skin at the site. The product goes into inflamed tissue and the inflammation becomes the problem. Treat the infection, wait for it to clear, and only then proceed.
• Active autoimmune disease, or immunosuppression. A biostimulator works by provoking a controlled inflammatory response, and that response is where the new collagen comes from. In a body with dysregulated immunity, "controlled" is no longer guaranteed. A stable, well-managed condition is a different conversation, and falls under relative.
• History of granulomatous disease or of granuloma formation in response to injectable material. Someone who has reacted that way once is more likely to react again.
• A tendency toward keloids or hypertrophic scarring, by the same reasoning: the healing response in that tissue is exaggerated by nature.

Can you get a biostimulator while pregnant?

No. And the reason isn't that there's a study showing harm — it's that there's no study showing safety.

No biostimulator has been tested in pregnant women. Nobody designs a clinical trial that injects an aesthetic product into pregnant women to see what happens; it would be unethical. So what exists is an absence of data, and an absence of data for an elective procedure can only be read one way: postpone.

It's the same logic that applies to toxin and to filler. There is no clinical urgency in any of it. Nothing a biostimulator addresses gets worse by waiting nine months.

Can you get Sculptra while breastfeeding?

Same answer, same reason — and there's a detail here that is usually poorly explained.

Poly-L-lactic acid is a particle that stays in the tissue and is broken down locally, over months. The question of whether it passes into breast milk is theoretical, and precisely because it's theoretical, it doesn't get resolved. It hasn't been tested.

On top of that, the postpartum body is in a different state: large hormonal swings, changing weight, fluctuating facial volume. Even if the product were proven safe, the timing is poor for judging a result — you'd be treating a face that is still going to change on its own.

At RUV the guidance is to wait until breastfeeding ends. It isn't excessive caution: an elective procedure has the luxury of choosing its moment.

Can you get a biostimulator if you have PMMA?

This is the most important question on this page, and the one most people ask after they've already had it injected.

PMMA is permanent. Polymethyl methacrylate isn't absorbed, isn't broken down and can't be removed with hyaluronidase — the enzyme that dissolves hyaluronic acid has no effect on it at all. The material stays where it was placed, encapsulated by fibrous tissue, and can react years later.

Placing a biostimulator over PMMA means deliberately provoking an inflammatory response in tissue that already has a permanent foreign body in it. That is exactly the scenario in which a delayed reaction to PMMA — which can already happen on its own — meets a trigger.

There's no generic "yes" or "no". What can honestly be said:

• A face with PMMA doesn't receive a biostimulator unless we know where the PMMA is. And "where it is" rarely matches where the person thinks it is, or what a report from years ago says.
• The patient doesn't always know she has it. Many people had "permanent filler" ten or fifteen years ago and don't know the product's name. Others had bioplasty — a PMMA procedure popular in Brazil — thinking it was hyaluronic acid.

It's one of the reasons the clinic performs a Doppler ultrasound assessment before the procedure — not to sell an exam, but to see the structure of that face before injecting. Doppler shows filler material from previous treatments, shows where it sits and in which plane, and that changes the plan. After the treatment, the same exam confirms there is no vessel compression.

Without that information, injecting a face with a filler history is deciding in the dark. With it, the conversation becomes technical: it may be possible to treat the clear areas, it may be possible to avoid the plane where the material sits, or it may turn out that this face is not a candidate — and we say so.

What are the risks of a collagen biostimulator?

The risks are real, and they divide by severity.

What matters most in that table isn't the product: it's injection plane, dilution and volume per point. A biostimulator placed too superficially, too concentrated, or in excess at a single point is the known recipe for nodules. Placed in the correct plane and well distributed, its safety profile is good.

Vascular risk is what justifies serious anatomical attention. Any product injected into the face can enter a vessel, and biostimulators have no reversal agent. That doesn't make the procedure dangerous — it makes the prior assessment non-negotiable.

What can go wrong with a biostimulator

Beyond the safety risks, there's a category of "it went wrong" that nobody calls a complication, but that disappoints:

• A result below expectations. Collagen is the body's response, and bodies vary. Age, smoking, skin quality and genetics all factor in. Nobody can guarantee how much collagen your body will produce.
• The wrong expectation. A biostimulator improves skin quality and firmness. It doesn't restore volume the way a filler does, and it doesn't lift very loose skin the way surgery does. Anyone who comes in expecting the result of something else leaves dissatisfied with a procedure that worked.
• The wrong area. Injecting where the complaint points rather than where the structure calls for it is the most common mistake. Midface sagging is rarely solved by treating only the midface.
• Impatience. The result builds over months, and the initial swelling misleads in both directions: it gives the impression of an immediate result that later "disappears", and it prompts a hasty decision to inject more.

That last point is the biggest driver of overtreatment. Reassessing before collagen has had time to respond and concluding "it didn't work" leads to stacking session on session.

Can a collagen biostimulator cause fibrosis?

It can, and it's worth understanding the difference between three things that often get called by the same name.

Physiological fibrosis is the goal. The product stimulates fibroblasts, the fibroblasts produce collagen, the tissue becomes firmer. That is the intended effect.

A nodule is a localized buildup — product concentrated at one point, or a more intense collagen response in that area. Most are small, palpable and not visible. Many resolve with massage and time.

Excessive fibrosis or granuloma is the body's exaggerated, organized response to the material. It's rare, and when it appears it usually involves one of the ingredients I've already listed: high volume per point, too superficial a plane, or predisposed ground — autoimmune disease, a history of granuloma, PMMA at the site.

The practical point: problematic fibrosis is almost always the consequence of technique or poor patient selection. That's why screening matters more than the product brand.

What the assessment before treatment needs to cover

What gets asked and examined before deciding:

• Filler history — what, when, where, and whether any material remains. This is where Doppler comes in.
• Autoimmune disease, immunosuppressant use, long-term corticosteroids.
• Anticoagulants or antiplatelet drugs. Not necessarily a barrier, but it changes the conversation about bruising and requires coordination with whoever prescribed them — never stop them on your own.
• Active infection, including dental. A distant source of infection matters.
• Tendency toward keloids, history of reaction to injectables.
• Pregnancy, trying to conceive, breastfeeding.
• Expectations. That's screening too. Someone who wants volume doesn't want a biostimulator.

And before all of that, the whole-face analysis. The complaint points to the symptom; the plan starts from the structure. A face that complains of sagging cheeks may be asking for jaw support, and in that case the biostimulator goes somewhere else — or doesn't go in at all.

When we advise against it

• Pregnancy and breastfeeding. No safety data, and no urgency whatsoever.
• Active autoimmune disease or immunosuppression. The product's mechanism depends on inflammation that behaves.
• Active infection in the area, or a nearby source of infection. Postpone until it clears.
• A face with PMMA or permanent material without knowing exactly where it is. No imaging, no injection.
• History of granuloma or reaction to injectable material.
• When the complaint is volume, not skin quality. A biostimulator is not a filler. Promising that is selling the wrong product.
• When the sagging is advanced. There's a point at which the possible collagen response can't reach what the person wants, and the path is surgical. We say so at the assessment — not after three sessions.
• When the person wants a result two weeks from now. Collagen's timeline doesn't negotiate with a wedding date.

Frequently asked questions

Can you get a collagen biostimulator if you have PMMA?

It depends on knowing where the PMMA is and in which plane. Without that information — from imaging, not from memory or an old report — the answer is no. With it, we can assess whether there is a clear, safe area to treat, or conclude that this face is not a candidate.

Can you get Sculptra while breastfeeding?

No. There's no safety study in breastfeeding, and an elective procedure waits. Add to that the fact that the postpartum face is still changing on its own, which gets in the way of even assessing the result.

Can people with diabetes get a biostimulator?

Well-controlled diabetes is not an absolute contraindication. Uncontrolled diabetes is — worse healing and a higher risk of infection. It goes to individual assessment, with the endocrinologist in the conversation.

What about lupus, rheumatoid arthritis or Hashimoto's thyroiditis?

Active disease, no. Stable, well-controlled disease goes to individual assessment, and the conversation involves the rheumatologist or endocrinologist who follows the patient. It's not a decision to make alone in an aesthetic clinic.

Is there a minimum or maximum age?

There's no hard cutoff. What exists is indication: very young people rarely need it, because their own collagen production still keeps up. People with a lot of sagging rarely benefit enough, because the possible response can't meet the demand. The criterion is the structure of the face, not the number.

I had hyaluronic acid filler recently. Can I?

Hyaluronic acid is different from PMMA — it's absorbable and reversible. Even so, it matters to know where it is, because it changes the injection plane and how we read what is already volume in place. It also matters to respect an interval between procedures, so you don't stack inflammation in the same area.

If I have a reaction, can it be reversed?

There's no reversal agent for biostimulators the way hyaluronidase exists for hyaluronic acid. What exists is management: medication, massage, time, and in specific cases a procedure. That's the reason to inject with a conservative plan and reassess, instead of injecting a high volume all at once.